Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...

Launch prices for anticancer drugs covered under Medicare Part D continue to rise, even with recent Inflation Reduction Act ...

The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of ...

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...

Trump administration officials are expected to release more details on their plan to lower prescription drug prices in the ...

AI may provide an answer to the question of whether drugs initially developed and prescribed for non-neurodegenerative physical conditions can be used to treat individuals with Parkinson’s disease.

Breathing—a natural and essential process—can be an incredibly labored process for people with cystic fibrosis. CF, a genetic ...